A soluble (phthalocyaninato)copper(II) complex containing eight symmetrical benzo‐15‐crown‐5 substituents, namely {2,3,9,10,16,17,23,24‐octakis[[benzo‐15‐crown‐5)‐4′ ‐yl]oxymethyl]phthalocyaninato}copper(II) (2) from 1,2‐bis{[benzo‐15‐crown‐5)‐4′‐yl]oxymethyl}‐4,5‐dibromobenzene (1) and CuCN in quinoline or pyridine was synthesized. The crown‐ether groups in 2 were shown to prefer intramolecular complexation with alkali metal ions.
No takes yet. Share an insight, caveat, or question.
Özer Bekâroĝlu (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: